Bio-Techne TECH
NASDAQ TECH
$72.43 -0.02 (-0.03%)
As of: Sep 4, 2026 · 3:59 PM EDT

Bio-Techne (TECH) Net Shares Issued and Repurchased (2014 - 2026)

Analysis

Bio-Techne (TECH) Net Shares Issued and Repurchased (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Bio-Techne 11.29 Bn 11.03 Bn 211.39 Mn 988,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 988,000.00
Sep 30, 2025 900,000.00
Jun 30, 2025 1.82 Mn
Sep 30, 2024 800,000.00
Jun 30, 2024 1.17 Mn
Sep 30, 2023 800,000.00
Jun 30, 2023 2.35 Mn
Sep 30, 2022 2.30 Mn
Jun 30, 2022 1.39 Mn
Sep 30, 2021 300,000.00
Jun 30, 2021 3.05 Mn
Sep 30, 2020 700,000.00
Jun 30, 2020 752,000.00
Sep 30, 2019 700,000.00
Jun 30, 2019 917,000.00
Sep 30, 2018 900,000.00
Jun 30, 2018 1.09 Mn
Sep 30, 2017 600,000.00
Jun 30, 2017 1.14 Mn
Sep 30, 2016 1.00 Mn